Primary Care Clinics in John Day, OR Accepting Medicare
7 Primary Care Clinics found. Showing 1 - 7
 Mountain Valley Eye Care Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 401 W Main St, Suite A, John Day, OR 97845 Phone: 541-575-1819 Fax: 541-575-0965 |
Canyon Creek Clinic Clinic/Center - Primary Care Medicare: Medicare Enrolled Practice Location: 235 S Canyon Blvd, John Day, OR 97845 Phone: 541-575-1263 Fax: 541-575-0233 |
Grant County Health Department Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 528 E Main St, Suite E, John Day, OR 97845 Phone: 541-575-0429 |
Strawberry Wilderness Community Clinic Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 180 Ford Rd, John Day, OR 97845 Phone: 541-575-0404 Fax: 541-575-1124 |
Russel Nichols, Md, Pc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 135 Ford Rd, John Day, OR 97845 Phone: 541-575-2669 Fax: 541-575-2743 |
Blue Mountain Chiropractic Health Center Inc Clinic/Center Medicare: Medicare Enrolled Practice Location: 155 Nw 1st Ave, John Day, OR 97845 Phone: 541-575-1063 Fax: 541-575-5554 |
Lens Clinical Services Family Medicine Medicare: Medicare Enrolled Practice Location: 120 E Main St, John Day, OR 97845 Phone: 541-575-0629 Fax: 541-575-2342 |
News Archive
Gene therapy for advanced heart failure shows promising results
Phase I results of the first clinical trial of gene therapy for patients with advanced heart failure show the approach to be promising, with improvements in several measures of the condition's severity.
Meridian Bioscience third-quarter net sales decrease 11% to $33.9 million
Net sales for the third quarter of fiscal 2010 were $33,857,000 as compared to $38,240,000 for the same period of the prior fiscal year, a decrease of 11%. Net earnings for the third quarter of fiscal 2010 were $6,424,000 or $0.16 per diluted share, both decreases of 24%, compared to the third quarter of fiscal 2009. (Net earnings include $673,000 in Bioline acquisition costs or $0.01 per diluted share.) Diluted common shares outstanding for fiscal 2010 and 2009 were 41,151,000 and 41,191,000, respectively.
Adropin protein produced by the liver sends signal that fat is on the way in response to high-fat foods
After you eat a burger and fries or other fat-filled meal, a protein produced by the liver may send a signal that fat is on the way, suggests a report in the December issue of the journal Cell Metabolism , a Cell Press publication.
Tethys Bioscience raises $33 million to drive market uptake of PreDx Diabetes Risk Score blood test
Tethys Bioscience, Inc., a privately held company, announced today that the company has recently raised $33 million, comprising $23 million of venture financing and a $10 million working capital loan. Participants in the venture financing included new investors Greenspring Associates, Inc. (formerly Montagu Newhall Associates, Inc.) and Paul Capital Investments, as well as current investors.
› Verified 2 days ago